MagedMofiedGhalyMD

Radiation Oncology • Smithtown, NY

Central Nervous System Cancer, Gastrointestinal Cancer, Head & Neck

Assistant Professor, Radiation Medicine, Hofstra North Shore-LIJ

Join to view full profile

Dr. Ghaly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ghaly's full profile

Already have an account?

Office
989 W Jericho Tpke
Smithtown, NY 11787
Phone+1 631-864-5600

Fax+1 631-864-5612

Education & Training

New York-Presbyterian Brooklyn Methodist HospitalResidency, Radiation Oncology, 1998 - 2002
New York-Presbyterian Brooklyn Methodist HospitalInternship, Internal Medicine, 1997 - 1998
Cairo University School of MedicineClass of 1992

Certifications & Licensure

NY State Medical License 2002 - 2025
PA State Medical License 2001 - 2001
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2014
Newsday - Top Doctors on Long Island Castle Connolly, 2012-2014

Publications & Presentations

PubMed

Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2 phase II study design.
Sarah E Hoffe, Todd A Aguilera, Parag J Parikh, Maged M Ghaly, Joseph M Herman
Future Oncology. 2024-03-01
Clinical predictors of premature radiotherapy terminations in senior adults with oral cavity and laryngeal carcinoma.
Dylan J Cooper, Isabella Travaglia, Meytal Guller, Wesley J Talcott, Maged Ghaly
Head & Neck. 2024-02-01
3 citations
Rates of Occult Invasive Disease in Patients With Biopsy-Proven Oral Cavity Squamous Cell Carcinoma in Situ.
Dylan J Cooper, Yonah Ziemba, Lucio Pereira, Benjamin H Kann, Bhupesh Parashar
JAMA Otolaryngology-- Head & Neck Surgery. 2024-02-01

Press Mentions

Medical Grade Cement May Help Cancer Patients Whose Disease Has Spread to the SpineApril 18th, 2017
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in Its Core Focus Area of Cancer Supportive CareApril 19th, 2024
Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis ProductMay 28th, 2024